Nanomedicine Drug Delivery Global Market Report 2025
상품코드:1877828
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
나노의학 약물 전달 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 1,065억 1,000만 달러로 평가되었고, 2025년에는 1,233억 7,000만 달러에 달하고, CAGR 15.8%로 성장할 전망입니다. 지난 몇 년간의 성장은 만성 질환 증가, 표적 요법에 대한 수요 증가, 세계적인 건강 관리 지출 증가, 의약품 인프라 투자 확대, 종양학 분야의 나노의료 응용 범위 확대, 개인화된 치료 접근법에 대한 인식 증가로 인한 것으로 보입니다.
나노의학 약물 전달 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 2,193억 달러에 이르고, CAGR은 15.5%를 나타낼 전망입니다. 예측기간 동안의 성장요인으로는 세계적 고령화 인구 증가, 심혈관질환 및 신경질환 유병률 상승, 정밀의료 이니셔티브에 대한 주목 증가, 나노의료연구에 대한 정부 지원 확대, 신흥지역에서의 헬스케어 인프라 정비의 진전, 제약기업과 연구기관 간의 연계 강화 등이 있습니다. 예측기간의 주요 동향으로는 나노입자 기반의 약물 전달 시스템의 진전, 자극 응답성 나노 캐리어의 개량, 다기능 나노의료 플랫폼의 혁신, 생물학적 장벽 극복을 위한 나노 스케일 약물전달의 진보, 개별화 나노 치료제의 연구 개발, 제어 방출형 하이브리드 나노 캐리어 시스템의 진전 등을 들 수 있습니다.
향후 수년간, 맞춤형 의료의 보급 확대가 나노의학 약물 전달 시장의 성장을 견인할 것으로 예측됩니다. 맞춤형 의료란 유전자 프로파일이나 질환 하위 유형 등 환자 한 사람 한 사람의 고유 특성에 맞추어 치료·예방 전략을 조정하는 의료 접근법을 말합니다. 유전체과학과 분자과학의 진보에 의해 개인의 유전자 구성에 맞춘 치료가 가능해지고, 효능의 향상과 정밀한 표적 치료의 실현이 도모되기 때문에 맞춤형 의료의 도입은 증가 경향에 있습니다. 나노의학 약물 전달은 약물을 표적 세포로 정확하게 유도하고 환자별로 투여량과 제형을 조정함으로써 치료 효과를 높이고 부작용을 최소화하기 위해 맞춤형 의료를 보완합니다. 예를 들어 미국에 본사를 둔 국제비영리단체 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 미국 식품의약국(FDA)은 2023년 희소질환 환자를 위한 신규맞춤형 치료 16건을 승인했습니다. 이는 2022년 승인 건수 6건에서 증가하고 있습니다. 따라서 맞춤형 의료의 도입 확대가 나노의학 약물 전달 시장의 성장을 가속하고 있습니다.
나노의학 약물 전달 시장에서 활동하는 주요 기업은 표적 정밀도를 높이고 맞춤형 치료의 개발을 가속화하기 위해 AI를 활용한 나노 전달 플랫폼 등 첨단 약물전달 솔루션의 개발에 주력하고 있습니다. AI를 활용한 나노 전달 플랫폼은 인공지능을 이용하여 나노입자를 설계·최적화하고 약물의 정확한 표적화를 실현하는 선진적인 시스템으로 치료효과 향상, 유해작용 최소화, 맞춤 치료 접근법의 지원에 공헌합니다. 예를 들어, 2025년 9월에는 중국 바이오테크놀러지 기업 METiS TechBio가 의약품 개발과 전달을 변화시키는 것을 목적으로 한 AI 구동형 나노 전달 플랫폼 'NanoForge'를 발표했습니다. 이 시스템은 인공지능과 나노기술을 융합시켜 지질 나노입자 제형을 최적화하고 약물을 표적 조직에 직접 전달함으로써 보다 신속하고 안전하며 비용 효율적인 의약품 개발을 실현합니다. 이 혁신 기술은 mRNA와 같은 복잡한 분자에서 약물 전달의 주요 과제를 해결하고 프로그래밍 가능하고 적응 가능한 치료법으로 발전을 촉진하도록 설계되었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 나노의학 약물 전달 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 나노의학 약물 전달 시장 : 성장률 분석
세계의 나노의학 약물 전달 시장 실적 : 규모와 성장, 2019-2024
세계의 나노의학 약물 전달 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 나노의학 약물 전달 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 나노의학 약물 전달 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
나노입자
리포솜
미셀
덴드리머
나노튜브
기타 제품 유형
세계의 나노의학 약물 전달 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
경구
주사제
외용약
기타 투여 경로
세계의 나노의학 약물 전달 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
종양학
심혈관 질환
신경학
감염증
기타 용도
세계의 나노의학 약물 전달 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
병원
클리닉
연구기관
기타 최종 사용자
세계의 나노의학 약물 전달 시장 : 세분화 나노입자, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
고분자 나노입자
금속 나노입자
지질계 나노입자
자성 나노입자
양자점
세계의 나노의학 약물 전달 시장 : 세분화 리포솜, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
기존 리포솜
스텔스 리포솜
양이온성 리포솜
음이온성 리포솜
pH 감수성 리포솜
세계의 나노의학 약물 전달 시장 : 세분화 미셀, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
고분자 미셀
지질 미셀
양친매성 블록 공중합체 미셀
자극 응답성 미셀
혼합 미셀
세계의 나노의학 약물 전달 시장 : 세분화 덴드리머, 유형별, 분석과 예측
Polyamidoamine Dendrimers
Polypropylene Imine Dendrimers
Peptide Dendrimers
Carbohydrate Dendrimers
Hydroxyl-Terminated Dendrimers
세계의 나노의학 약물 전달 시장 : 서브세분화 나노튜브, 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
탄소나노튜브
펩티드 나노튜브
무기 나노튜브
다층 나노튜브
단층 탄소나노튜브
세계의 나노의학 약물 전달 시장 : 세분화 기타 제품 유형, 유형별, 분석과 예측
나노스피어
나노캡슐
나노에멀젼
나노겔
하이브리드 나노 캐리어
제7장 지역별/국가별 분석
세계의 나노의학 약물 전달 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
세계의 나노의학 약물 전달 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
나노의학 약물 전달 시장 : 경쟁 구도
나노의학 약물 전달 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Novartis AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Gilead Sciences Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Evonik Industries AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Ipsen Pharma SAS
Pacira BioSciences Inc.
Camurus AB
Arcturus Therapeutics Holdings Inc.
Nanobiotix SA
Acuitas Therapeutics Inc.
NanoViricides Inc.
Taiwan Liposome Company Ltd.
Aphios Corporation
Concept Medical Inc.
DelSiTech Ltd.
ANP Technologies Inc.
ProMab Biotechnologies Inc.
BlueWillow Biologics Inc.
Nanoform Finland Plc
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
나노의학 약물 전달 시장 2029 : 새로운 기회를 제공하는 국가
나노의학 약물 전달 시장 2029 : 새로운 기회를 제공하는 부문
나노의학 약물 전달 시장 2029 : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Nanomedicine drug delivery involves the use of nanoscale materials and technologies to transport therapeutic agents directly to specific targets within the body. This approach enhances treatment precision and control, ensuring optimal interaction with disease sites. Nanomedicine drug delivery improves drug stability, absorption, and bioavailability, resulting in more effective therapeutic outcomes. Its key benefit is the reduction of systemic exposure while maximizing the therapeutic effect.
The primary product types of nanomedicine drug delivery include nanoparticles, liposomes, micelles, dendrimers, nanotubes, and others. Nanoparticles serve as nanoscale carriers that deliver therapeutic agents directly to targeted cells or tissues, improving drug efficacy and reducing side effects. These drug delivery systems can be administered through various routes such as oral, injectable, topical, and others. They are used in several therapeutic areas, including oncology, cardiovascular diseases, neurology, infectious diseases, and others, and are employed by end users such as hospitals, clinics, research institutes, and other healthcare facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The nanomedicine drug delivery market research report is one of a series of new reports from The Business Research Company that provides nanomedicine drug delivery market statistics, including nanomedicine drug delivery industry global market size, regional shares, competitors with a nanomedicine drug delivery market share, detailed nanomedicine drug delivery market segments, market trends and opportunities, and any further data you may need to thrive in the nanomedicine drug delivery industry. The nanomedicine drug delivery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The nanomedicine drug delivery market size has grown rapidly in recent years. It will grow from $106.51 billion in 2024 to $123.37 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. Growth during the historic period can be attributed to the increasing prevalence of chronic diseases, rising demand for targeted therapies, growing global healthcare expenditure, greater investment in pharmaceutical infrastructure, expansion of nanomedicine applications in oncology, and rising awareness of personalized treatment approaches.
The nanomedicine drug delivery market size is expected to see rapid growth in the next few years. It will grow to $219.30 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth during the forecast period can be attributed to the rising global aging population, the increasing prevalence of cardiovascular and neurological disorders, the growing emphasis on precision medicine initiatives, the rise in government support for nanomedicine research, the development of healthcare infrastructure in emerging regions, and the strengthening collaborations between pharmaceutical and research organizations. Key trends in the forecast period include progress in nanoparticle-based drug carriers, improvements in stimuli-responsive nanocarriers, innovations in multifunctional nanomedicine platforms, advancements in nanoscale drug delivery for overcoming biological barriers, research and development in personalized nanotherapeutics, and progress in hybrid nanocarrier systems for controlled release.
The increasing adoption of personalized medicine is expected to drive the growth of the nanomedicine drug delivery market in the coming years. Personalized medicine refers to a medical approach that tailors treatment and prevention strategies to the unique characteristics of each patient, such as genetic profile or disease subtype. The adoption of personalized medicine is rising as advances in genomics and molecular science enable treatments customized to an individual's genetic makeup, improving effectiveness and supporting precise, targeted care. Nanomedicine drug delivery complements personalized medicine by accurately directing drugs to target cells and adjusting dosages and formulations for each patient, improving therapeutic outcomes and minimizing side effects. For example, in February 2024, according to the Personalized Medicine Coalition, a United States-based international non-profit organization, the United States Food and Drug Administration approved sixteen new personalized treatments for patients with rare diseases in 2023, up from six approvals in 2022. Therefore, the increasing adoption of personalized medicine is propelling the growth of the nanomedicine drug delivery market.
Leading companies operating in the nanomedicine drug delivery market are focusing on developing advanced drug delivery solutions, such as AI-powered nano-delivery platforms, to enhance targeting precision and accelerate the development of personalized therapies. AI-powered nano-delivery platforms are advanced systems that use artificial intelligence to design and optimize nanoparticles for accurate drug targeting, improving therapeutic performance, minimizing adverse effects, and supporting individualized treatment approaches. For instance, in September 2025, METiS TechBio, a China-based biotechnology company, introduced NanoForge, an AI-driven nano-delivery platform aimed at transforming medicine development and delivery. The system combines artificial intelligence with nanotechnology to optimize lipid nanoparticle formulations and deliver drugs directly to target tissues, enabling faster, safer, and more cost-effective drug development. This innovation is designed to address major challenges in drug delivery for complex molecules such as mRNA, advancing the field toward programmable and adaptive therapeutics.
In July 2024, ME Therapeutics Inc., a Canada-based preclinical-stage immuno-oncology company, entered into a partnership with NanoVation Therapeutics Inc. to develop advanced messenger ribonucleic acid (mRNA) delivery systems aimed at targeting myeloid cells for cancer treatment. Through this collaboration, ME Therapeutics seeks to utilize NanoVation's proprietary long-circulating lipid nanoparticle platform to improve the precision, efficacy, and in vivo targeting of mRNA therapeutics, accelerating the development of new treatments in the nanomedicine drug delivery sector. NanoVation Therapeutics Inc. is a Canada-based biotechnology company specializing in the design and development of lipid nanoparticle technologies for nucleic acid delivery.
Major players in the nanomedicine drug delivery market are Pfizer Inc., Bristol-Myers Squibb Company, Novartis AG, Gilead Sciences Inc., Evonik Industries AG, Ipsen Pharma S.A.S., Pacira BioSciences Inc., Camurus AB, Arcturus Therapeutics Holdings Inc., Nanobiotix S.A., Acuitas Therapeutics Inc., NanoViricides Inc., Taiwan Liposome Company Ltd., Aphios Corporation, Concept Medical Inc., DelSiTech Ltd., ANP Technologies Inc., ProMab Biotechnologies Inc., BlueWillow Biologics Inc., and Nanoform Finland Plc.
North America was the largest region in the nanomedicine drug delivery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nanomedicine drug delivery report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the nanomedicine drug delivery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The nanomedicine drug delivery market consists of revenues earned by entities by providing services such as drug formulation services, nanocarrier design services, clinical trial management services, regulatory consulting services, contract research services, and contract manufacturing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nanomedicine drug delivery market also includes sales of nanocarrier-based drug formulations, targeted drug delivery systems, sustained release nanomedicines, polymeric nanoparticles, lipid-based nanocarriers, and nanoemulsions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Nanomedicine Drug Delivery Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on nanomedicine drug delivery market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for nanomedicine drug delivery ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The nanomedicine drug delivery market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Nanoparticles; Liposomes; Micelles; Dendrimers; Nanotubes; Other Product Types
2) By Route Of Administration: Oral; Injectable; Topical; Other Routes Of Administration
3) By Application: Oncology; Cardiovascular Diseases; Neurology; Infectious Diseases; Other Applications
4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Nanoparticles: Polymeric Nanoparticles; Metallic Nanoparticles; Lipid-Based Nanoparticles; Magnetic Nanoparticles; Quantum Dots
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Nanomedicine Drug Delivery Market Characteristics
3. Nanomedicine Drug Delivery Market Trends And Strategies
4. Nanomedicine Drug Delivery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Nanomedicine Drug Delivery Growth Analysis And Strategic Analysis Framework
5.1. Global Nanomedicine Drug Delivery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nanomedicine Drug Delivery Market Growth Rate Analysis
5.4. Global Nanomedicine Drug Delivery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nanomedicine Drug Delivery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nanomedicine Drug Delivery Total Addressable Market (TAM)
6. Nanomedicine Drug Delivery Market Segmentation
6.1. Global Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanoparticles
Liposomes
Micelles
Dendrimers
Nanotubes
Other Product Types
6.2. Global Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Injectable
Topical
Other Routes Of Administration
6.3. Global Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology
Cardiovascular Diseases
Neurology
Infectious Diseases
Other Applications
6.4. Global Nanomedicine Drug Delivery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Research Institutes
Other End-Users
6.5. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymeric Nanoparticles
Metallic Nanoparticles
Lipid-Based Nanoparticles
Magnetic Nanoparticles
Quantum Dots
6.6. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Conventional Liposomes
Stealth Liposomes
Cationic Liposomes
Anionic Liposomes
pH-Sensitive Liposomes
6.7. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Micelles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymeric Micelles
Lipid Micelles
Amphiphilic Block Copolymer Micelles
Stimuli-Responsive Micelles
Mixed Micelles
6.8. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polyamidoamine Dendrimers
Polypropylene Imine Dendrimers
Peptide Dendrimers
Carbohydrate Dendrimers
Hydroxyl-Terminated Dendrimers
6.9. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Nanotubes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carbon Nanotubes
Peptide Nanotubes
Inorganic Nanotubes
Multi-Walled Nanotubes
Single-Walled Nanotubes
6.10. Global Nanomedicine Drug Delivery Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nanospheres
Nanocapsules
Nanoemulsions
Nanogels
Hybrid Nanocarriers
7. Nanomedicine Drug Delivery Market Regional And Country Analysis
7.1. Global Nanomedicine Drug Delivery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nanomedicine Drug Delivery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Nanomedicine Drug Delivery Market
8.1. Asia-Pacific Nanomedicine Drug Delivery Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Nanomedicine Drug Delivery Market
9.1. China Nanomedicine Drug Delivery Market Overview
9.2. China Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Nanomedicine Drug Delivery Market
10.1. India Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Nanomedicine Drug Delivery Market
11.1. Japan Nanomedicine Drug Delivery Market Overview
11.2. Japan Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Nanomedicine Drug Delivery Market
12.1. Australia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Nanomedicine Drug Delivery Market
13.1. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Nanomedicine Drug Delivery Market
14.1. South Korea Nanomedicine Drug Delivery Market Overview
14.2. South Korea Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Nanomedicine Drug Delivery Market
15.1. Western Europe Nanomedicine Drug Delivery Market Overview
15.2. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Nanomedicine Drug Delivery Market
16.1. UK Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Nanomedicine Drug Delivery Market
17.1. Germany Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Nanomedicine Drug Delivery Market
18.1. France Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Nanomedicine Drug Delivery Market
19.1. Italy Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Nanomedicine Drug Delivery Market
20.1. Spain Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Nanomedicine Drug Delivery Market
21.1. Eastern Europe Nanomedicine Drug Delivery Market Overview
21.2. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Nanomedicine Drug Delivery Market
22.1. Russia Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Nanomedicine Drug Delivery Market
23.1. North America Nanomedicine Drug Delivery Market Overview
23.2. North America Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Nanomedicine Drug Delivery Market
24.1. USA Nanomedicine Drug Delivery Market Overview
24.2. USA Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Nanomedicine Drug Delivery Market
25.1. Canada Nanomedicine Drug Delivery Market Overview
25.2. Canada Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Nanomedicine Drug Delivery Market
26.1. South America Nanomedicine Drug Delivery Market Overview
26.2. South America Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Nanomedicine Drug Delivery Market
27.1. Brazil Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Nanomedicine Drug Delivery Market
28.1. Middle East Nanomedicine Drug Delivery Market Overview
28.2. Middle East Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Nanomedicine Drug Delivery Market
29.1. Africa Nanomedicine Drug Delivery Market Overview
29.2. Africa Nanomedicine Drug Delivery Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nanomedicine Drug Delivery Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nanomedicine Drug Delivery Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Nanomedicine Drug Delivery Market Competitive Landscape And Company Profiles
30.1. Nanomedicine Drug Delivery Market Competitive Landscape
30.2. Nanomedicine Drug Delivery Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Evonik Industries AG Overview, Products and Services, Strategy and Financial Analysis
31. Nanomedicine Drug Delivery Market Other Major And Innovative Companies
31.1. Ipsen Pharma S.A.S.
31.2. Pacira BioSciences Inc.
31.3. Camurus AB
31.4. Arcturus Therapeutics Holdings Inc.
31.5. Nanobiotix S.A.
31.6. Acuitas Therapeutics Inc.
31.7. NanoViricides Inc.
31.8. Taiwan Liposome Company Ltd.
31.9. Aphios Corporation
31.10. Concept Medical Inc.
31.11. DelSiTech Ltd.
31.12. ANP Technologies Inc.
31.13. ProMab Biotechnologies Inc.
31.14. BlueWillow Biologics Inc.
31.15. Nanoform Finland Plc
32. Global Nanomedicine Drug Delivery Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Nanomedicine Drug Delivery Market
34. Recent Developments In The Nanomedicine Drug Delivery Market
35. Nanomedicine Drug Delivery Market High Potential Countries, Segments and Strategies
35.1 Nanomedicine Drug Delivery Market In 2029 - Countries Offering Most New Opportunities
35.2 Nanomedicine Drug Delivery Market In 2029 - Segments Offering Most New Opportunities
35.3 Nanomedicine Drug Delivery Market In 2029 - Growth Strategies
